NYSE:WSTLife Sciences
Evaluating West Pharmaceutical Services (WST) Valuation As Earnings And GLP 1 Growth Stay In Focus
Why West Pharmaceutical Services Is Back in Focus Ahead of Earnings
West Pharmaceutical Services (WST) is drawing fresh attention as investors look ahead to its earnings report this Thursday, after the company previously beat earnings and revenue expectations and raised full-year 2025 guidance.
See our latest analysis for West Pharmaceutical Services.
At a share price of US$243.56, West Pharmaceutical Services has seen a 5.46% 7 day share price return, a 30 day share price return of 11.60%...